| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |